They have been studied in heart failure and kidney disease, and empagliflozin in particular is one of what cardiologists now call the "Fantastic Four" drug classes in the treatment of heart failure with reduced ejection fraction
This multi-target approach sets it apart from older treatments, offering a more comprehensive solution for people struggling with obesity and related conditions like type 2 diabetes
Several other indications are under study, including obstructive sleep apnea, MASLD, knee osteoarthritis, chronic kidney disease, and cardiovascular outcomes
Several GLP-1 receptor agonists are available through the NHS and private prescription in the United Kingdom, each with distinct pharmacokinetic profiles and administration schedules
This kind of mobile polish reduces input errors, keeps buttons comfortably spaced, and preserves clarity even on smaller screens